C. Andreadis

997 total citations
18 papers, 660 citations indexed

About

C. Andreadis is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, C. Andreadis has authored 18 papers receiving a total of 660 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 5 papers in Surgery and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in C. Andreadis's work include Bone health and treatments (4 papers), Cancer Treatment and Pharmacology (4 papers) and Bone and Joint Diseases (4 papers). C. Andreadis is often cited by papers focused on Bone health and treatments (4 papers), Cancer Treatment and Pharmacology (4 papers) and Bone and Joint Diseases (4 papers). C. Andreadis collaborates with scholars based in Greece and United States. C. Andreadis's co-authors include Αthanassios Kyrgidis, Konstantinos Vahtsevanos, Stefanos Triaridis, Georgios Koloutsos, Ioannis Boukovinas, Kyriaki Kitikidou, Evgenia Verrou, Panagiotis Paraskevopoulos, Κωνσταντίνος Αντωνιάδης and Konstantinos Zervas and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Urology and European Journal of Cancer.

In The Last Decade

C. Andreadis

17 papers receiving 633 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Andreadis Greece 8 563 424 119 76 74 18 660
H. Gamm Germany 9 250 0.4× 155 0.4× 76 0.6× 41 0.5× 33 0.4× 17 478
Yasmin Rahim Canada 9 439 0.8× 76 0.2× 32 0.3× 165 2.2× 115 1.6× 17 542
Francesco Pietrogrande Italy 11 174 0.3× 141 0.3× 71 0.6× 35 0.5× 16 0.2× 21 352
Tadateru Sumi Japan 11 78 0.1× 103 0.2× 43 0.4× 43 0.6× 205 2.8× 15 665
Bjarne Hauge Hansen Denmark 13 300 0.5× 22 0.1× 88 0.7× 221 2.9× 485 6.6× 18 652
Hiroya Kato Japan 6 38 0.1× 60 0.1× 85 0.7× 121 1.6× 86 1.2× 10 367
Conor Shortt Ireland 12 144 0.3× 99 0.2× 35 0.3× 32 0.4× 131 1.8× 20 515
Munenori Watanuki Japan 10 42 0.1× 50 0.1× 174 1.5× 154 2.0× 95 1.3× 26 338
Stefan Bruijnen Netherlands 10 60 0.1× 57 0.1× 163 1.4× 32 0.4× 57 0.8× 15 359
Carmen Martini Germany 11 71 0.1× 28 0.1× 64 0.5× 113 1.5× 160 2.2× 16 369

Countries citing papers authored by C. Andreadis

Since Specialization
Citations

This map shows the geographic impact of C. Andreadis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Andreadis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Andreadis more than expected).

Fields of papers citing papers by C. Andreadis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Andreadis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Andreadis. The network helps show where C. Andreadis may publish in the future.

Co-authorship network of co-authors of C. Andreadis

This figure shows the co-authorship network connecting the top 25 collaborators of C. Andreadis. A scholar is included among the top collaborators of C. Andreadis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Andreadis. C. Andreadis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Koumarianou, Anna, Flora Zagouri, Christos Papadimitriou, et al.. (2020). ABREAST: a prospective, real-world study on the effect of nab-paclitaxel treatment on clinical outcomes and quality of life of patients with metastatic breast cancer. Breast Cancer Research and Treatment. 182(1). 85–96. 3 indexed citations
3.
Kyrgidis, Αthanassios, Maria P. Yavropoulou, Roza Lagoudaki, et al.. (2016). Increased CD14+ and decreased CD14− populations of monocytes 48 h after zolendronic acid infusion in breast cancer patients. Osteoporosis International. 28(3). 991–999. 7 indexed citations
4.
Kyrgidis, Αthanassios, et al.. (2010). Reply to I. Abraham. Journal of Clinical Oncology. 28(9). e145–e147.
5.
Pectasides, Dimitrios, Eirini Pectasides, George Papaxoinis, et al.. (2009). Primary fallopian tube carcinoma: Results of a retrospective analysis of 64 patients. Gynecologic Oncology. 115(1). 97–101. 32 indexed citations
6.
Vahtsevanos, Konstantinos, Αthanassios Kyrgidis, Evgenia Verrou, et al.. (2009). Longitudinal Cohort Study of Risk Factors in Cancer Patients of Bisphosphonate-Related Osteonecrosis of the Jaw. Journal of Clinical Oncology. 27(32). 5356–5362. 352 indexed citations
7.
Kyrgidis, Αthanassios, Konstantinos Vahtsevanos, Georgios Koloutsos, et al.. (2008). Bisphosphonate-Related Osteonecrosis of the Jaws: A Case-Control Study of Risk Factors in Breast Cancer Patients. Journal of Clinical Oncology. 26(28). 4634–4638. 162 indexed citations
8.
Vahtsevanos, Konstantinos, et al.. (2007). Distant bone metastases from carcinoma of the lip: a report of four cases. International Journal of Oral and Maxillofacial Surgery. 36(2). 180–185. 7 indexed citations
9.
Andreadis, C., et al.. (2005). Non-invasive cardiologic findings in patients with malignant melanoma*. Melanoma Research. 15(5). 441–446. 4 indexed citations
10.
Andreadis, C., et al.. (2005). Significance of Immunocytochemical Expression of E-Cadherin, N-Cadherin and CD44 in Serous Effusions Using Liquid-Based Cytology. Acta Cytologica. 49(1). 11–16. 11 indexed citations
11.
Gennatas, C., Despina Mouratidou, Νicolas Tsavaris, et al.. (2005). Gemcitabine in combination with vinorelbine for heavily pretreated advanced breast cancer. Journal of Clinical Oncology. 23(16_suppl). 741–741. 5 indexed citations
12.
Andreadis, C., et al.. (2005). SERUM CYFRA 21–1 IN PATIENTS WITH INVASIVE BLADDER CANCER AND ITS RELEVANCE AS A TUMOR MARKER DURING CHEMOTHERAPY. The Journal of Urology. 174(5). 1771–1776. 33 indexed citations
13.
Gennatas, C., et al.. (2005). Docetaxel and mitoxantrone, versus docetaxel mitoxantrone and letrozole as first-line therapy in advanced breast cancer: A randomized study. Journal of Clinical Oncology. 23(16_suppl). 722–722. 1 indexed citations
14.
Zavos, Christos, et al.. (2004). A hypothesis on the role of insulin-like growth factor I in testicular germ cell tumours. Medical Hypotheses. 63(3). 511–514. 7 indexed citations
15.
Andreadis, C., et al.. (2004). Combined chemotherapy and radiotherapy during conception and first two trimesters of gestation in a woman with metastatic breast cancer. Gynecologic Oncology. 95(1). 252–255. 30 indexed citations
16.
Andreadis, C., et al.. (2004). P-02 Cardiac metastases from malignant melanoma. Melanoma Research. 14(4). A18–A18. 1 indexed citations
17.
Papaxoinis, George, et al.. (2004). Advanced colorectal carcinoma. Journal of Clinical Oncology. 22(14_suppl). 3655–3655. 1 indexed citations
18.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H. Gamm Breakdown of academic impact, for papers by Yasmin Rahim Breakdown of academic impact, for papers by Francesco Pietrogrande Breakdown of academic impact, for papers by Tadateru Sumi Breakdown of academic impact, for papers by Bjarne Hauge Hansen Breakdown of academic impact, for papers by Hiroya Kato Breakdown of academic impact, for papers by Conor Shortt Breakdown of academic impact, for papers by Munenori Watanuki Breakdown of academic impact, for papers by Stefan Bruijnen Breakdown of academic impact, for papers by Carmen Martini
Rankless by CCL
2026